Integra Lifesciences Holdings Corp (NAS:IART)
$ 29.07 0.95 (3.38%) Market Cap: 2.29 Bil Enterprise Value: 1.71 Bil PE Ratio: 58.14 PB Ratio: 0.79 GF Score: 77/100

Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 12:30AM GMT
Release Date Price: $57.04 (-1.89%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to have our next session with Integra LifeSciences, bringing up Jan De Witte, the new CEO for a presentation, and then we'll do some questions and answers.

Jan De Witte
Integra LifeSciences Holdings Corporation - President, CEO & Director

Okay. Thank you, Robbie. As he said, I'm Jan de Witte, still a relatively fresh new CEO of Integra LifeSciences. I'm here with Carrie Anderson, our CFO. She's going to join me up here for the Q&A together with Robbie after.

But first things first, our safe harbor disclosure reminded that some of the statements I'll be making are forward-looking.

But let's get started. I think that many of you here in the room or on the webcast follow Integra for several years. I do hope that there are some people who do not know Integra that well and come away after this presentation as excited as I am about the potential of Integra LifeSciences.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot